ESC 365 - Metoprolol improves left ventricular longitudinal function at rest and during exercise in obstructive hypertrophic cardiomyopathy

ESC Professional Premium Access

Metoprolol improves left ventricular longitudinal function at rest and during exercise in obstructive hypertrophic cardiomyopathy

Session: Hypertrophic cardiomyopathy: not so rare, but not so easy

Topic: Hypertrophic Cardiomyopathy

Speaker: Mrs A. Dybro (Aarhus, DK)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Mrs Anne Dybro

Aarhus University Hospital, Aarhus (Denmark)

0 follower

4 more presentations in this session

Mavacamten induces a clinical, hemodynamic, and biomarker response beyond the primary endpoint in EXPLORER-HCM: results from a post hoc machine learning analysis

Speaker: Doctor I. Olivotto (Florence, IT)

Prevalence and clinical correlates of clinical red flags for rare diseases in consecutive patients presenting with HCM phenotype

Speaker: Doctor N. Maurizi (Lausanne, CH)

Temporal trends, characteristics and comorbidities of patients with hypertrophic cardiomyopathy in denmark from 2005-2018: A nationwide cohort study.

Speaker: Doctor C. Zoerner (Copenhagen, DK)

Representativeness of EXPLORER-HCM trial and prevalence of eligibility criteria for Mavacamten in a nationwide cohort

Speaker: Doctor M. Brandao (Vila Nova de Gaia, PT)

Access the full session

Hypertrophic cardiomyopathy: not so rare, but not so easy

Speakers: Mrs A. Dybro, Doctor I. Olivotto, Doctor N. Maurizi, Doctor C. Zoerner, Doctor M. Brandao

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources